Creating Erasmus MC Kanker Instituut Trials

From Beacon

Warning: You are recreating a page that was previously deleted.

You should consider whether it is appropriate to continue editing this page. The deletion and move log for this page are provided here for convenience:

  • 01:49, 23 June 2024 Victor talk contribs deleted page Erasmus MC Kanker Instituut Trials (content was: "'''NCTID''': NCT05208047 '''Title''': (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors '''Study Summary''': This is a Phase 3, open-label, international, multicenter study of CGT9486 in combination with sunitinib. This is a multi-part study that will enroll approximately 426 patients. Part 1 consists of...", and the only contributor was "Woloski" (talk))
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
Please note that all contributions to Beacon may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see Beacon:Copyrights for details). Do not submit copyrighted work without permission!
Cancel Editing help (opens in new window)